Proteomic profiling of endometrial tissue and plasma from mares with endometrial fibrosis
Authors:
- Natacha D MuderspachNMNatacha D Muderspach
- Rune DauckeRDRune Daucke
- Kirsten E ScogginKirsten E Scoggin
- Carleigh E FedorkaCarleigh E Fedorka
- Lynda M J MillerLMLynda M J Miller
- Mats H T TroedssonMTMats H T Troedsson
- Graça Ferreira-DiasGraça Ferreira-Dias
- Jørgen S AgerholmJAJørgen S Agerholm
- Erwin M SchoofESErwin M Schoof
- 27 September 2025
- journal article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 114 (1) , 158-173
Abstract
Endometrial fibrosis leads to subfertility when periglandular fibrosis impairs endometrial gland function. Identifying distinct protein expressions in mares suffering from this condition is essential for understanding the pathogenesis and developing treatments to delay fibrotic progression. To gain a better understanding of protein dynamics underlying this condition, Data-Independent Acquisition Mass Spectrometry was utilized to comprehensively characterize and compare the equine endometrial and plasma proteome from mares with different severities of endometrial fibrosis. Mares in diestrus were selected as controls (n = 9), moderate endometrial fibrosis (n = 9), and severe endometrial fibrosis (n = 9), based on examination of tissue sections stained with hematoxylin and eosin and immunohistochemically marked for alpha-smooth muscle actin. Approximately 10,000 proteins were identified in endometrial tissue and 500 in plasma. Between moderate fibrosis and controls, 310 and 75 differed in endometrial tissue and plasma, respectively, and between severe fibrosis and controls, 585 and 71 differed, respectively. Extracellular matrix-related pathways were over-represented among upregulated proteins in endometrial tissue from mares with moderate and severe fibrosis. Several of the proteins involved appear to promote development or progression of fibrosis. Immune-related pathways were over-represented among downregulated proteins in mares with moderate fibrosis, and among upregulated proteins in mares with severe fibrosis. Several of the proteins highlighted by our analysis have both immunologic and fibrotic properties. We anticipate that the extensive profiling of endometrial and plasma proteome paves the way for identification of potential diagnostic biomarkers and targets for therapeutic use in equine endometrial fibrosis.Keywords
Funding Information
- The Danish Horse Levy Foundation, Lincoln Memorial Grant (23LM001)
- Augustinus Foundation Denmark (21-1766)
This publication has 105 references indexed in Scilit:
- An enhanced label‐free proteomics approach for deep‐diving into equine plasma proteome, including the discovery of protein biomarkers for strenuous exerciseDrug Testing and Analysis, 2023
- Sphingomyelin phosphodiesterase 1 (SMPD1) mediates the attenuation of myocardial infarction-induced cardiac fibrosis by astaxanthinBiochemical and Biophysical Research Communications, 2018
- Diverse biological activities of the vascular non-inflammatory molecules – The Vanin pantetheinasesBiochemical and Biophysical Research Communications, 2012
- Endometrial fibrotic changes. Is one biopsy enough to diagnose degenerative changes?Animal Reproduction Science, 2010
- The equine endometrosis: New insights into the pathogenesisAnimal Reproduction Science, 2009
- Body fluid proteomics: Prospects for biomarker discoveryProteomics – Clinical Applications, 2007
- A novel human dendritic cell-derived C1r-like serine protease analog inhibits complement-mediated cytotoxicityBiochemical and Biophysical Research Communications, 2004
- Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysisInternational Journal of Cancer, 2003
- The contribution of complement to opsonic activity in the uterine secretions of mares free of endometritisTheriogenology, 1993
- Relationships of age to uterine function and reproductive efficiency in maresTheriogenology, 1992